Genetic counseling, prenatal screening and diagnosis of Down syndrome in the second trimester in women of advanced maternal age: A prospective study

Chinese Medical Journal

Volumn 126, Issue 11, 2013, Pages 2007-2010

  Qi, Qing Wei ^a   Jiang, Yu Lin ^a   Zhou, Xi Ya ^a   Liu, Jun Tao ^a   Yin, Jie ^a   Bian, Xu Ming ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Advanced maternal age; Down syndrome; Genetic amniocentesis; Genetic counseling; Prenatal screening; Second trimester

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL;

ADULT; AMNIOCENTESIS; ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FLUOROIMMUNOASSAY; GENETIC COUNSELING; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRENATAL SCREENING; PREVALENCE; PROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY;

ADULT; AMNIOCENTESIS; DOWN SYNDROME; FEMALE; GENETIC COUNSELING; HUMANS; MATERNAL AGE; MIDDLE AGED; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES;

EID: 84878707714     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20122345     Document Type: Article

References (21)

1. Lau TK, Fung HY, Rogers MS, Cheung KL. Racial variation in incidence of trisomy 21: survey of 57,742 Chinese deliveries. Am J Med Genet 1998; 75: 386-388.
2. Dommergues M, Audibert F, Benattar C, Champagne C, Gomel V, Frydman R. Is routine amniocentesis for advanced maternal age still indicated? Fetal Diagn Ther 2001; 16: 372-377.
3. Benn PA, Egan JF, Fang M, Smith-Bindman R. Changes in the utilization of prenatal diagnosis. Obstet Gynecol 2004; 103: 1255-1260.
4. Johnson JP, Streets K, Fitzgerald J, Priest J, Vanisko M, Haag M. Influence of triple-marker screen risk versus a priori risk in decision for amniocentesis in women of advanced maternal age. Prenat Diagn 1998; 18: 979-980.
5. Hodges RJ, Wallace EM. Testing for Down syndrome in the older woman: a risky business? Aust N Z J Obstet Gynecol 2005; 45: 486-488.
6. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and Second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess 2003; 7: 1-77.
7. Wald NJ, Rodeck C, Hackshaw AK, Rudnicka A. SURUSS in perspective. BJOG 2004; 111: 521-531.
8. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. New Engl J Med 2005; 353: 2001-2011.
9. Liao C, Huang Y, Li D, Song S, Yi C, Zhou J. Second-trimester maternal serum screening for Down syndrome in Mainland China. Prenat Diagn 2006; 26: 1271-1272.
10. ACOG Practice Bulletin No. 77: Screening for fetal chromosomal abnormalities. Obstet Gynecol 2007; 109: 217-227.
11. Qi QW, Jiang YL, Liu JT, Bian XM, Li Y, Lü SM, et al. Second trimester maternal serum screening for Down's syndrome in women of advanced maternal age: a multi-center prospective study. Chin J Obset Gynecol (Chin) 2008; 43: 737-741.
12. Hsu LY, Benn PA. Revised guidelines for the diagnosis of mosaicism in amniocytes. Prenat Diagn 1999; 19: 1081-1082.
13. Sherman Elias. Amniocentesis and fetal blood sampling. In Genetic Disorders and the Fetus: Diagnosis, Prevention, and Treatment. Milunsky A, Milunsky JM, eds. Oxford: Wiley- Blackwell; 2010: 63-93.
14. Benn PA. Advances in prenatal screening for Down syndrome: I general principles and second trimester testing. Clin Chim Acta 2002; 323: 1-16.
15. Ferguson-Smith MA, Yates JR. Maternal age specific rates for chromosome aberrations and factors influencing them: report of a collaborative European study on 52,965 amniocenteses. Prenat Diagn 1984; 4: 5-44.
16. Benn PA, Fang M, Egan JF. Trends in the use of second trimester maternal serum screening from 1991 to 2003. Genet Med 2005; 7: 328-331.
17. Nakata N, Wang Y, Bhatt S. Trends in prenatal screening and diagnostic testing among women referred for advanced maternal age. Prenat Diagn 2010; 30: 198-206.
18. Hills A, Donaghue C, Waters J, Waters K, Sullivan C, Kulkarni A, et al. QF-PCR as a stand-alone test for prenatal samples: the first 2 years' experience in the London region. Prenat Diagn 2010; 30: 509-517.
19. Boormans EM, Birnie E, Oepkes D, Galjaard RJ, Schuring- Blom GH, van Lith JM, et al. Comparison of multiplex ligation-depentdent probe amplification and karyotyping in prental diagnosis. Obstet Gynecol 2010; 115: 297-303.
20. Gross SJ, Bajaj K, Garry D, Klugman S, Karpel BM, Roe AM, et al. Rapid and novel prenatal molecular assay for detecting aneuploidies and microdeletion syndromes. Prenat Diagn 2011; 31: 259-266.
21. ACOG Committee Opinion No. 446: Array comparative genomic hybridization in prenatal diagnosis. Obstet Gynecol 2009; 114: 1161-1163.